GT Biopharma to Participate in the 10th Anniversary of the Innate Killer Summit
Provided By GlobeNewswire
Last update: Mar 4, 2025
SAN FRANCISCO, CALIFORNIA, March 04, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary TriKE® natural killer (NK) cell engager platform, today announced that Jeffrey Miller, MD1 from the University of Minnesota Medical School2 will participate as an expert speaker at the 10th Anniversary of the Innate Killer Summit being held March 3-5, 2025 in San Diego, CA.
Read more at globenewswire.comNASDAQ:GTBP (3/7/2025, 8:00:01 PM)
2.44
+0.07 (+2.95%)
Find more stocks in the Stock Screener
GTBP Latest News and Analysis
13 days ago - ChartmillTraders are paying attention to the gapping stocks in Tuesday's session.The session on Tuesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
13 days ago - ChartmillWhat's going on in today's pre-market sessionLet's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.
